Enhanced antimicrobial activity of peptide-cocktails against common bacterial contaminants of ex vivo stored platelets  K.V.K. Mohan, S. Sainath Rao,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients  C. Andersen, B.C. Kahl,
Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens.
Gut bacterial microbiota and obesity
M.A.C. Broeren, Y. Maas, E. Retera, N.L.A. Arents 
M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans 
Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
Survival of influenza virus on human fingers
Cross-resistance to human cationic antimicrobial peptides and to polymyxins mediated by the plasmid-encoded MCR-1?  J. Dobias, L. Poirel, P. Nordmann 
M. Kanaa, M.J. Wright, J.A.T. Sandoe 
Clinical impact of antibiotic-resistant Gram-positive pathogens
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
R. Cantón  Clinical Microbiology and Infection 
T. Schmidt, J. Zündorf, T. Grüger, K. Brandenburg, A. -L. Reiners, J
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli  R.A. Hickman, D. Hughes,
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
P. Moreillon, J.M. Entenza  Clinical Microbiology and Infection 
S. Khelaifia, M. Drancourt  Clinical Microbiology and Infection 
Pharmacodynamics of doxycycline
Training for the infectious diseases speciality in Norway
Bacterial resistance—the clinical challenge
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
False synergy between vancomycin and β-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods 
Clinical Microbiology and Infection  Volume 9, Pages (January 2003)
M. Or, M. Samish, T. Waner, S. Harrus 
G. Kronvall  Clinical Microbiology and Infection 
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
M. Aires-de-Sousa  Clinical Microbiology and Infection 
J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W
T.M. File  Clinical Microbiology and Infection 
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens.
Antibacterial drug discovery in the 21st century
Pandemic lineages of extraintestinal pathogenic Escherichia coli
P.M. Hawkey  Clinical Microbiology and Infection 
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values  J. Turnidge, G. Kahlmeter,
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan 
Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock.
C. Gagliotti, L. Nobilio, M.L. Moro 
S. Stepanović, V. Djukić, V. Djordjević, S. Djukić 
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals  M.E. Reverdy, S. Jarraud, S. Bohin-Duhreux, E.
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
M.B. Kerrn, N. Frimodt-Møller, F. Espersen 
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.
Lymphocyte subset numbers depend on the bacterial origin of sepsis
In-vitro evaluation of the adhesion to polypropylene sutures of non-pigmented, rapidly growing mycobacteria  N. Zamora, J. Esteban, T.J. Kinnari, A. Celdrán,
Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release  J. SjöUlin,
Abstracts Clinical Microbiology and Infection
Zoonotic Chlamydophila psittaci infections from a clinical perspective
New oral cephalosporins in pediatric community-acquired infections
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory 
Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents    Clinical Microbiology and Infection  Volume.
B.A. Cunha  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Abstracts Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Enhanced antimicrobial activity of peptide-cocktails against common bacterial contaminants of ex vivo stored platelets  K.V.K. Mohan, S. Sainath Rao, Y. Gao, C.D. Atreya  Clinical Microbiology and Infection  Volume 20, Issue 1, Pages O39-O46 (January 2014) DOI: 10.1111/1469-0691.12326 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Illustration of antimicrobial activity of PD and RW peptides and their combinations. Plasma (striped columns) and platelet (filled columns) samples were spiked with six different medically important bacteria and co-incubated with either PD or RW peptides individually or in combinations at 10 μM concentrations. Bacterial titres were estimated by plating a fixed volume of the incubation mix and performing a colony count. Samples without any peptides but spiked with individual bacterial strain were treated as controls. The peptide combinations demonstrate enhanced microbicidal activity against most of the bacteria tested in both plasma and platelet samples. Results are presented as mean ± SD. (**p <0.0001, *p <0.001). Clinical Microbiology and Infection 2014 20, O39-O46DOI: (10.1111/1469-0691.12326) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Analyses of antimicrobial activity of combinatorial peptides against various bacteria. The most potent combinations are RW2 + RW4, RW2 + RW3 + RW4, PD3 + RW3 + RW4 and PD4 + RW3 + RW4 exhibiting a 1000- to 10 000-fold reduction of bacterial titres. Also note two other peptide combinations (RW2 + RW3 and RW3 + RW4) that effectively resulted in a 10-to 10 000-fold reduction of the six tested bacteria. Clinical Microbiology and Infection 2014 20, O39-O46DOI: (10.1111/1469-0691.12326) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Demonstration of MIC of four selected peptide combinations based on their potent action. Serial two-fold dilutions of the peptide combinations were carried out with final concentration ranging among 10, 5, 2.5, 1.25 and 0.6 μM and incubated with the respective bacteria. As illustrated in the figure, peptide combinations RW2 + RW4, RW2 + RW3 + RW4, and PD4 + RW3 + RW4 were effective even at 5 μM concentration and brought about a 1000- to 10 000-fold reduction of all six tested bacteria. The PD3 + RW3 + RW4 combination, however, was effective in bringing about only a 2-log reduction at 5 μM concentration. Clinical Microbiology and Infection 2014 20, O39-O46DOI: (10.1111/1469-0691.12326) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 4 Illustration of time-kill kinetics of three most potent peptide combinations. Log-phase cultures of two bacterial species, Staphylococcus aureus and Escherichia coli representing gram-positive and gram-negative bacteria, were treated with peptide combinations at a concentration of 10 μM and bacterial numbers were estimated at time-points 0–120 min. As observed in the figure the peptide combinations exhibited enhanced antimicrobial activity resulting in a 100- and 1000-fold reduction of bacterial titres within 20 and 60 min of incubation, respectively. Clinical Microbiology and Infection 2014 20, O39-O46DOI: (10.1111/1469-0691.12326) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 5 Transmission electron microscopy to illustrate the effects of peptide treatment on bacteria. Structural changes elicited by the peptides on bacteria were evaluated on two bacterial species, Staphylococcus aureus and Escherichia coli representing gram-positive and gram-negative bacteria that were treated individually with PD4, RW2, RW3 or RW4 peptides. Controls included bacteria without peptide treatment and electron microscopy analysis reveals a normal morphology and structural integrity of both Staphylococcus aureus and Escherichia coli cells. Peptide treatment on the other hand revealed a multitude of structural changes in the treated bacteria such as loss of structural integrity, ballooning of cells, loss of cytoplasmic content, and cytoplasmic granulation. Certain bacterial cells also exhibited formation of bulbar structures or protrusions from the cell surface. Scale: 500 nm. Clinical Microbiology and Infection 2014 20, O39-O46DOI: (10.1111/1469-0691.12326) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions